#PoolbegPharma
LightNews LightNews
financialtalk.bsky.social
#PoolbegPharma (AIM:POLB) CEO #JeremySkillington joined Proactive's Stephen Gunnion to discuss the dosing of the first patient in its TOPICAL clinical trial evaluating POLB-001 for the prevention of cytokine release syndrome in multiple myeloma patients youtu.be/-DkrA_KTXVY
…
Poolbeg Pharma doses first patient in TOPICAL clinical trial
YouTube video by Proactive Investors
youtu.be
July 13, 2026 at 3:38 PM
pharmaphorum.bsky.social
#PoolbegPharma is preparing to start a #clinicaltrial of a drug that aims to block a life-threatening side effect of #cancerimmunotherapies, and hopes to have its first data in the summer.

pharmaphorum.com/news/poolbeg...
Poolbeg expects first data for CRS drug in the summer
A trial to see if Poolbeg's POLB-001 can prevent cytokine release syndrome in multiple myeloma treated with immunotherapy Tecvayli will start soon.
pharmaphorum.com
June 16, 2026 at 11:30 AM
financialtalk.bsky.social
#ActiveEnergy, #QuantumBlockchainTechnologies, #Metir, #PoolbegPharma, IXICO, #CoiledTherapeutics youtu.be/mtYaRJogN-c
Active Energy, Quantum Blockchain Technologies, Metir, Poolbeg Pharma, IXICO, Coiled Therapeutics
YouTube video by Proactive Investors
youtu.be
June 14, 2026 at 4:45 PM